Drugs / AG-858
last change Apr 2006 re-read 2 minutes ago

AG-858

Developed for
chronic myeloid leukemia
Investigated by
Agenus Inc.

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00058747 Mar 2003 → Apr 2006 chronic myeloid leukemia Agenus Inc. Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AG-858 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00058747